# name
Post-Acute COVID Syndrome (PACS): Definition, Impact and Management

# metadata.dc.description[].value
Additional support from ISGlobal’s Antoni Plasència and Josep M. Antó

# metadata.dc.description.abstract[].value
A variety of studies suggest that up to 10-15% of all patients with COVID-19 may present persistent symptomatology weeks or even months after the original
infection. Given the accumulated burden of COVID-19 in Catalonia, Spain, we speculate that over 90,000 patients could have been or are currently affected by
persistent symptoms or sequelae.  The Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC) presents its third report where they propose a clear set of case definitions of Post-Acute COVID syndrome (PACS) and its sub-categories and recommend a comprehensive medical examination to characterise the clinical features and complications when assessing PACS.

# metadata.dc.publisher[].value
Institut de Salut Global de Barcelona (ISGlobal)

# metadata.dc.publisher[].value
Col·legi Oficial de Metges de Barcelona (COMB)

# metadata.dc.rights[].value
cc-by (c) Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC), 2021

# metadata.dc.source[].value
Documents de treball / Informes (ISGlobal)

# metadata.dc.title[].value
Post-Acute COVID Syndrome (PACS): Definition, Impact and Management